Clinical Trial Update: Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion [Phase 2]

View source ↗

Summary

Phase 2 safety and preliminary efficacy study of NeoFuse in subjects requiring lumbar interbody fusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Degenerative Spondylolisthesis
• Spinal Stenosis

Drugs mentioned

• NeoFuse

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis | Phase 2 | Status: COMPLETED